A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus. (Q51501369)
Jump to navigation
Jump to search
scientific article published on 22 March 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus. |
scientific article published on 22 March 2006 |
Statements
A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus. (English)
1 reference
1 reference
Meindert Danhof
1 reference
Willem de Winter
1 reference
Teun Post
1 reference
Bart Ploeger
1 reference
Richard Urquhart
1 reference
Ian Moules
1 reference
David Eckland
1 reference
22 March 2006
1 reference
33
1 reference
3
1 reference
313-343
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference